CVS Health Corporation (CVS)
4 Medical Stocks With the Right Setup for Q2 Earnings Beats
CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
How Safe Is CVS Health's Dividend?
CVS Health (NYSE:CVS | CVS Price Prediction) shares closed at $106.89 on July 23, 2026, up 78.2% over the past year.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends
Healthcare is quietly becoming the value hunter's playground of 2026. While the mega cap tech trade keeps sucking up oxygen, two of the largest healthcare names in the S&P 500 are trading at forward multiples that look mispriced against their earnings power.
CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing
The latest trading day saw CVS Health (CVS) settling at $110.6, representing a +2.78% change from its previous close.
CVS is now filling prescriptions for dogs and cats. Here's what pet owners need to know
Next time you need to fill your pet's prescription, you might be able to pick up your own at the same time. Tuesday CVS Health announced plans to carry dog and cat medications alongside human ones in its pharmacies.
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, CVS Health (CVS) stood at $102.81, denoting a -1.59% move from the preceding trading day.
